Survey No. : RH2020-03 | Sample sent on : 2020/08/24 | Reporting deadline : 2020/08/31 |
Sample sent : 20 set | Results reported (%) : 20 (100%) |
Summary Report of G6PD and Hemoglobin (Hb) Quantitative Test Results
Lab | Referral Hosp. |
Report (day) |
G6PD Reagent Code |
Sample 1 | Sample 2 | Sample 3 | Hb 1 | Hb 2 | Hb 3 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(U/g Hb) | D% | z score | SDI | (U/g Hb) | D% | z score | SDI | (U/g Hb) | D% | z score | SDI | (g/dL) | (g/dL) | (g/dL) | ||||||||||||||||||||||||
RH01 | RH01 RH05 |
1 | 3 | 4.9 | 11.4% | 1.6 | 1.8 | 20.1 | 12.3% | 1.8 | 2.0 | 5.5 | 25.0% | 3.6 | 3.9 | 2.2 | 2.2 | 2.2 | ||||||||||||||||||||
RH02 | RH02 | 4 | 4 | 4.3 | -2.3% | -0.3 | -0.4 | 18.5 | 3.4% | 0.5 | 0.6 | 4.5 | 2.3% | 0.3 | 0.4 | 2.2 | 2.3 | 2.2 | ||||||||||||||||||||
RH04 | RH04 | 7 | 4 | 4.3 | -2.3% | -0.3 | -0.4 | 16.5 | -7.8% | -1.1 | -1.1 | 4.1 | -6.8% | -1.0 | -1.1 | 2.2 | 2.3 | 2.2 | ||||||||||||||||||||
RH06 | RH06 | 7 | 3 | 4.3 | -2.3% | -0.3 | -0.4 | 17.9 | 0.0% | 0.0 | 0.1 | 4.6 | 4.5% | 0.6 | 0.7 | 2.2 | 2.2 | 2.1 | ||||||||||||||||||||
RH07 | RH07 A0189 |
4 | 4 | 4.8 | 9.1% | 1.3 | 1.4 | 18.6 | 3.9% | 0.6 | 0.7 | 4.9 | 11.4% | 1.6 | 1.8 | 1.9 | 2.0 | 1.9 | ||||||||||||||||||||
RH08 | RH08 | 7 | 3 | 4.4 | 0.0% | 0.0 | 0.0 | 18.2 | 1.7% | 0.2 | 0.4 | 4.4 | 0.0% | 0.0 | 0.0 | 2.2 | 2.2 | 2.2 | ||||||||||||||||||||
RH09 | RH09 | 7 | 4 | 4.5 | 2.3% | 0.3 | 0.4 | 17.2 | -3.9% | -0.6 | -0.5 | 4.4 | 0.0% | 0.0 | 0.0 | 1.9 | 2.0 | 2.0 | ||||||||||||||||||||
RH10 | RH10 | 2 | 4 | 4.1 | -6.8% | -1.0 | -1.1 | 20.1 | 12.3% | 1.8 | 2.0 | 4.1 | -6.8% | -1.0 | -1.1 | 2.0 | 2.0 | 2.0 | ||||||||||||||||||||
RH12 | RH12 | 7 | 4 | 4.7 | 6.8% | 1.0 | 1.1 | 18.5 | 3.4% | 0.5 | 0.6 | 4.8 | 9.1% | 1.3 | 1.4 | 2.1 | 2.2 | 2.1 | ||||||||||||||||||||
RH13 | RH13 | 7 | 4 | 4.3 | -2.3% | -0.3 | -0.4 | 16.5 | -7.8% | -1.1 | -1.1 | 4.4 | 0.0% | 0.0 | 0.0 | 2.2 | 2.2 | 2.2 | ||||||||||||||||||||
RH14 | RH14 | 7 | 3 | 4.2 | -4.5% | -0.6 | -0.7 | 17.7 | -1.1% | -0.2 | -0.1 | 4.2 | -4.5% | -0.6 | -0.7 | 2.3 | 2.3 | 2.3 | ||||||||||||||||||||
RH19 | RH19 | 2 | 4 | 4.5 | 2.3% | 0.3 | 0.4 | 16.7 | -6.7% | -1.0 | -1.0 | 4.3 | -2.3% | -0.3 | -0.4 | 2.2 | 2.2 | 2.2 | ||||||||||||||||||||
A0203 | RH18 A0203 |
7 | 3 | 4.4 | 0.0% | 0.0 | 0.0 | 17.7 | -1.1% | -0.2 | -0.1 | 4.5 | 2.3% | 0.3 | 0.4 | 2.2 | 2.3 | 2.2 | ||||||||||||||||||||
G026 | G026 | 7 | 4 | 4.4 | 0.0% | 0.0 | 0.0 | 18.8 | 5.0% | 0.7 | 0.9 | 4.5 | 2.3% | 0.3 | 0.4 | 2.2 | 2.2 | 2.1 | ||||||||||||||||||||
CL001 | RH16 | 1 | 4 | 4.4 | 0.0% | 0.0 | 0.0 | 18.2 | 1.7% | 0.2 | 0.4 | 4.4 | 0.0% | 0.0 | 0.0 | 2.1 | 2.2 | 2.1 | ||||||||||||||||||||
CL002 | RH03 RH11 RH17 G031 B005 CL016 A0511 |
7 | 1 | 4.1 | -6.8% | -1.0 | -1.1 | 16.2 | -9.5% | -1.4 | -1.4 | 4.2 | -4.5% | -0.6 | -0.7 | 2.2 | 2.2 | 2.2 | ||||||||||||||||||||
CL004 | CL004 | 7 | 3 | 3.9 | -11.4% | -1.6 | -1.8 | 17.6 | -1.7% | -0.2 | -0.2 | 4.4 | 0.0% | 0.0 | 0.0 | 2.2 | 2.1 | 2.1 | ||||||||||||||||||||
CL014 | CL014 | 7 | 3 | 3.7 | -15.9% | -2.3 | -2.5 | 18.3 | 2.2% | 0.3 | 0.4 | 3.9 | -11.4% | -1.6 | -1.8 | 2.2 | 2.2 | 2.2 | ||||||||||||||||||||
CL015B | CL015B | 7 | 3 | 4.5 | 2.3% | 0.3 | 0.4 | 17.8 | -0.6% | -0.1 | 0.0 | 4.5 | 2.3% | 0.3 | 0.4 | 2.2 | 2.3 | 2.3 | ||||||||||||||||||||
CL017 | CL017 | 3 | 4 | 4.7 | 6.8% | 1.0 | 1.1 | 16.2 | -9.5% | -1.4 | -1.4 | 4.7 | 6.8% | 1.0 | 1.1 | 2.1 | 2.1 | 2.1 | ||||||||||||||||||||
Total participating laboratories = 20 | ||||||||||||||||||||||||||||||||||||||
Xa (Median) | - | 7 | - | 4.4 | 17.9 | 4.4 | 2.2 | 2.2 | 2.2 | |||||||||||||||||||||||||||||
uXa | - | - | - | 0.069 | 0.280 | 0.069 | - | - | - | |||||||||||||||||||||||||||||
σp | - | - | - | 0.308 | 1.253 | 0.308 | - | - | - | |||||||||||||||||||||||||||||
σp′ | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||
Range | - | 1-7 | - | 3.7-4.9 | 16.2-20.1 | 3.9-5.5 | 1.9-2.3 | 2.0-2.3 | 1.9-2.3 | |||||||||||||||||||||||||||||
n | - | - | - | 20 | 20 | 20 | 20 | 20 | 20 | |||||||||||||||||||||||||||||
Mean | - | - | - | 4.4 | 17.8 | 4.4 | 2.2 | 2.2 | 2.1 | |||||||||||||||||||||||||||||
SD | - | - | - | 0.28 | 1.14 | 0.28 | 0.00 | 0.10 | 0.10 | |||||||||||||||||||||||||||||
CV | - | - | - | 6.4% | 6.4% | 6.4% | 0.0% | 4.5% | 4.8% | |||||||||||||||||||||||||||||
|
G6PD Reagent Code |
Lab |
|
Innovation | 3 | A0203, CL004, CL014, CL015B, RH01, RH06, RH08, RH14 |
Lanner | 4 | CL001, CL017, G026, RH02, RH04, RH07, RH09, RH10, RH12, RH13, RH19 |
Trinity | 1 | CL002 |
Newborn Screening QA Program |
|
||||
P.O. Box 624, Taipei Xinwei, Taipei City 10699, Taiwan | University of the Philippines | ||||
Tel : + 886-2-2703-6080; Fax : +886-2-2703-6070 | 625 Pedro Gil St., Ermita, Manila 1000, Philippines | ||||
Fax : + 632-522-4396; | |||||
updated : 01 Sep, 2020 |
|